Search Results
Results found for "Can Cao"
- Misread the Curve, Misjudge the Drug: Rethinking Antagonism in GPCR Pharmacology
In GPCR drug discovery, a single mistaken assumption can derail an entire program. also explores the experimental constraints —like timing and equilibrium—that determine whether you can shape alone is diagnostic, pointing out how features like receptor reserve or irreversible binding can
- How Schild Analysis Protects Your Conclusions in GPCR Research
Welcome back GPCR Fans, Clean data can still mislead if the underlying assumptions aren’t tested. But if the underlying criteria aren’t tested, that assumption can quietly erode the reliability of your Quantify affinity you can defend.
- Class B1 GPCR Dimerization: Unveiling Its Role in Receptor Function and Signaling
While GPCRs can exist as monomers, some types, like class C GPCRs, are obligate dimers, either as homodimers class B GPCRs, however, has been more controversial, despite increasing evidence that these receptors can These dimeric forms, which can either be transient or stable, are believed to influence the function Recent studies suggest that class B1 GPCRs can form both homodimers and heterodimers, which may play
- What If the Most Important Part of Your Drug Isn’t What It Binds—But What It Does?
You'll learn why some agonists succeed in sensitive tissues but fail elsewhere—and how this knowledge can
- How to Use Statistical Methods to Strengthen Every GPCR Drug Discovery Decision
Trusting your eyes—or tradition—can cost time, money, and credibility. walks you through which statistical tests actually answer the question you think you’re asking—so you can Get an answer you can defend. Unlock Terry’s Corner ➤ Dr.
- Fluorescence Polarization in GPCR Research
Using this method, binding affinity, kinetics and selectivity can all be measured and used to establish This combined with the use of polarized light leads to a signal that can only be detected when the fluorescent Conventional membrane preparations or baculoviruses can be used among others.
- When the Islet Lit Up: Advancing GPCR Imaging in Native Tissue
I can image the whole islet. A single successful GPCR imaging experiment can transform a project’s trajectory. Better GPCR imaging doesn’t just capture biology — it expands the biological questions the field can
- Biased Agonism at the GLP-1 Receptor: A Pathway to Improved Therapeutic Outcomes
However, GLP-1R can also engage other G proteins, such as Gi/o and Gq/11, leading to different downstream Biased agonism at the GLP-1R has been extensively studied, revealing that different ligands can stabilize These differences in signaling profiles can have significant physiological implications. observed to reduce adipose tissue size more effectively than exendin, suggesting that biased agonism can
- GPCR Agonist-to-Antagonist Conversion: Enabling the Design of Nucleoside Functional Switches for...
simultaneously interact with both Ser2777.42 and His2787.43, 2 only transiently contacts His2787.43, which can This approach can expand the repertoire of adenosine receptor antagonists that can be designed based
- Do You Believe AI Could Accelerate Drug Discovery?
By using machine learning, AF2 can accurately predict the 3D structures of GPCRs with atomic-level accuracy concern is the reliance on data quality and quantity, where inaccuracies or biases in training data can Moreover, advanced AI models like AlphaFold3, which can predict complex protein-molecule interactions
- Ever Wondered How Drugs Are Discovered?
and First in Class projects—and why both are essential Why target-based discovery is powerful, but can
- Your GPCR Program Decisions Depend on Good Data Interpretation
Subtle misinterpretation can quietly derail projects, slow timelines, and waste scarce resources. GPCR , we’re focusing on the hidden risks that undermine progress and how the right frameworks can keep But Terry Kenakin’s new Emerging Drug Hunter lecture reveals why this assumption can mislead even experienced
- VAMP2: a crucial player in the delivery of MOR to the synapse
In addition, VAMP2 can interact with other GPCRs, such as the beta-2 adrenergic receptor and the mu-opioid in the case of MOR, which is a receptor with several splicing variants, its traffic to the membrane can the integrity of its bi-leucine sequence (which is considered a key element in its recycling), which can receptor regulates pain perception and reward, the dysfunction in the MOR-SNARE complex interaction can You can consult the article at the following link: https://www.ecosystem.drgpcr.com/structural-and-molecular-insights-into-gpcr-function
- Targeted Therapies to Reduce Side Effects in Modern Drug Development
two reasons why researchers typically require years to uncover the mechanisms of disease before they can potential toxicities and side effects, and these key factors must be deemed tolerable before investigators can cells, has the drawback of causing damage to healthy cells in the process, leading to side effects that can
- How Collaboration Drives GPCR Discoveries
in vivo work, structural experts for cryo-EM, chemists for tool development, and data scientists who can No one person can be excellent at all of it — and pretending otherwise slows discovery. It will hinge on the teams who can map GPCR signaling with precision and design therapies that fit real
- APEX2/AUR Biosensor: A Powerful Tool for Protein Interaction and Trafficking
During this process, APEX2 can label proteins in the vicinity, allowing the capture of a snapshot of When AUR is oxidized by APEX2 in the presence of H 2 O 2 , it produces a fluorescent product that can
- Exclusive Access: Terry's Corner is LIVE + Your Premium Member Discount!
In the meantime, you can get a sneak peek by exploring Terry's Articles , which offer complementary insights
- Targeting GPCRs in the CNS: Advances in Drug Discovery Strategies
When the endogenous binder of the GPCR (which can be a neuromodulator, neurotransmitter, etc.), binds Depending on the type of GPCR, it can lead to different secondary messengers , like cAMP, IP3, which advantages of using fluorescent ligands for this are: Live-cell imaging: receptor-ligand interactions can
- How Advanced GPCR Kinetics Sharpen Decision Making (and Save You Time)
We’re zeroing in on kinetic tools that reveal what steady-state data can’t—so you can vet leads faster These are the pattern-recognition tools that convert uncertainty into decisions you can defend at a project We’ve got your GPCR Track, Happy Hour, and sessions mapped so you can extract maximum value.
- Beyond the Probe: Scaling Innovation From the Bench to Product Launch
. 👉 See how Celtarys can support your drug discovery workflow on the company page . _______________
- Antibodies That Don’t Block, They Activate: A New Angle on Autoimmunity and GPCRs
The Tools to Detect Them Using the multiplexed GPCR library and Luminex assay , researchers can now:
- How to Avoid the Most Common Gaps in Your Biotech Pitch
The Most Common Mistakes in Biotech Pitches Even the most brilliant science can get lost in a poor pitch And the good news is, they can be fixed. Strong biotech pitches don’t just inform, they align. When the listener knows exactly who your solution targets, they can immediately place it in their mental
- Chemerin Forms: Their Generation and Activity
Chemerin can signal via two G protein-coupled receptors, chem1 and chem2, as well as be bound to a third and secreted into the circulation as a precursor, but it is also expressed in some tissues where it can
- 📰 GPCR Weekly News, April 29 to May 5, 2024
In the meantime, you can always check the Classified GPCR News from the last weeks.
- Fluorescent Ligands Targeting Intracellular Allosteric Binding Site of the Chemokine Receptor CCR2
Fluorescently labeled ligands are versatile molecular tools to study G protein-coupled receptors (GPCRs) and can Further, we show that 14 can be used as a tool for fragment-based screening approaches.
- Reflections on My PhD Journey: Lessons Learned
generating data when experiments are working smoothly, but neglecting to analyze that data in real-time can One of the best pieces of advice I can give is to analyze your results as you progress.
- FDA Approval Is a Strategy Obstacle, Not a Paperwork Problem
actually optimizing for, and where most early-stage teams fall short: 1️⃣ Predictable safety margins: Can 3️⃣ Manufacturing consistency: Can you show that your process will be scalable, repeatable, and GMP-compliant doubt slows down approval. ✅ The sooner you understand what they’re optimizing for, the faster you can
- Conservation of Allosteric Ligand Binding Sites in G-Protein Coupled Receptors
Mapping of Alphafold2 generated models of these proteins confirms that the same sites can be identified These sites cluster at nine distinct locations, and each can be found in many different proteins.
- 📰 GPCR Weekly News, February 27 to March 5, 2023
Keep in mind that you can always change your email preferences in your account settings. There is no limit to the number of posters we can accommodate, so hurry and submit your poster so that we can add it to the list of posters and increase the number of people who can ''stop by'' it on March
- An overview of the compartmentalized GPCR Signaling: Relevance and Implications
Showing that this spatially biased signaling through arrestins can influence transcriptional responses addition to endosomal signaling, GPCRs are also known to localize to the Golgi apparatus, where they can Activation of nuclear GPCRs, such as the metabotropic glutamate receptor 5 (mGluR5), can lead to sustained both temporal and spatial components, sustained signaling responses from intracellular compartments can Additionally, the conditions within endosomes, such as low pH and high protease activity, can degrade

















